The Food and Drug Administration (FDA) has approved Susvimo ® (ranibizumab injection) for the treatment of patients with diabetic retinopathy who have previously responded to at least 2 intravitreal ...

Patients with COPD and established cardiovascular disease have more MACEs and seek less preventive cardiac care than patients with CVD alone.

There are similarities and differences in the sources of sodium and sodium reduction behaviors between racial and ethnic groups.

Post hoc results support the initiation of SGLT2 inhibitors in patients with diabetic nephropathy regardless of iron deficiency. Canagliflozin treatment may improve iron markers and hemoglobin levels ...

Hypoxemia went undetected in 0.8% of critically ill Asian patients when oxygen saturation was measured via pulse oximetry (SpO2) vs SaO2.

A study has found that there are racial and ethnic differences related to shared decision making among patients with hypertension.

The AHA’s PREVENT equations, compared with pooled cohort equations, can better predict 10-year ASCVD risk among US adults.

As of mid-May, this variant has been identified in nearly 11 percent of sequenced samples reported worldwide. The WHO has designated this variant as a “variant under monitoring,” and currently ...

Patients with RSV hospitalization have increased odds of any acute cardiovascular event compared with COVID-19 hospitalizations.

There is a lack of medical training addressing clinician weight bias despite the implicit bias that exists in some future providers.

Male athletes with high-volume exercise training have a higher burden of calcified plaque than male nonathletes.

SGLT-2 inhibitor use vs DPP-4 inhibitor use was associated with lower incidence of epilepsy among patients with type 2 diabetes.